SAN DIEGO, Feb. 4, 2015 (GLOBE NEWSWIRE) -- AltheaDx today announced an agreement with the Cardiovascular Institute of the South (CIS) to implement AltheaDx's IDgenetix testing portfolio within their system. The IDgenetix pharmacogenetic (PGx) testing portfolio enables personalized therapeutic decisions for patients suffering from some of the most prevalent clinical conditions including cardiovascular disease, neuropsychiatric disorders, and pain.
The IDgenetix testing portfolio will assist CIS in identifying optimal drugs for their patients as well as dosing guidelines based on a patient's genetic make-up, current prescription regimen and other key factors. IDgenetix is designed to enable healthcare providers to make timely and evidence-based decisions, reduce the overall cost of patient care by reducing adverse events, optimizing patients' overall therapeutic regimen and helping to achieve a faster therapeutic response.
"We are excited to be working with progressive and forward thinking institutions like Cardiovascular Institute of the South to implement the IDgenetix testing portfolio and improving patient care through the implementation of personalized medicine," said Greg Hamilton, CEO of AltheaDx.
AltheaDx is a commercial stage molecular diagnostics company which focuses on enabling physicians, managed care organizations, pharmaceutical companies and other healthcare entities to make personalized therapeutic decisions for patients. AltheaDx's IDgenetix pharmacogenetic product testing portfolio addresses some of the most prevalent clinical conditions in the United States, including cardiovascular disease, neuropsychiatric disorders and pain. AltheaDx is a CAP-accredited, CLIA-certified laboratory located in San Diego, CA.
About Cardiovascular Institute of the South (CIS)
CIS is one of the most respected groups of cardiologists, representing nearly every specialty in heart and circulatory medicine. With a team of nearly 500 dedicated team members, and 40 physicians, CIS serves communities throughout Louisiana, as well as national and international patients, at its 14 clinics. CIS consistently positions itself at the forefront of technology by providing the most up-to-date technology coupled with compassionate care. This mission has guided the institute for more than 31 years of service to south Louisiana. For more information about CIS, call 1-800-425-2565 or visit www.cardio.com.
CONTACT: Kristen Nungesser ICR, Inc. (646) 277-1261 firstname.lastname@example.orgSource:AltheaDx, Inc.